Alopecia Areata Market Analysis, Trends, Share, Industry Growth Rate And Forecast To 2032

The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company's Alopecia Areata Global Market Report 2023 identifies growing prevalence of hair loss as the major driver for the alopecia areata market's growth in the forecast period. Hair loss is caused by disrupting the body's normal hair growth cycle. Alopecia areata treatment employs corticosteroids, potent anti-inflammatory medications that can inhibit the immune system, to treat a condition where the immune system destroys hair follicles and results in hair loss.

The global alopecia areata market is expected to grow from $3.08 billion in 2022 to $3.31 billion in 2023 at a compound annual growth rate (CAGR) of 7.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and resulted in increased interest rates affecting many markets across the globe. The alopecia areata market is expected to reach $4.35 billion in 2027 at a CAGR of 7.1%.

Download Free Sample Of Alopecia Areata Market Report -
https://www.thebusinessresearchcompany.com/sample_request?id=12596&type=smp

Major competitors in the alopecia areata market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Novartis AG, Bristol-Myers Squibb Company, Sanofi S.A., GlaxoSmithKline plc., Eli Lilly and Co Ltd.

A key trend in the alopecia areata market includes innovative drug approval. Major companies operating in the alopecia areata market are focused on obtaining new drug approvals to strengthen their market position and gain a competitive advantage. For instance, in June 2023, Pfizer Inc., a US-based biotechnology and pharmaceutical company, announced that the US Food and Drug Administration (FDA), a US-based federal agency of the Department of Health and Human Services responsible for protecting public health, had approved LITFULOTM (ritlecitinib), the first and only treatment for severe alopecia areata approved for patients as young as 12. It is a once-daily oral treatment for alopecia areata, an autoimmune condition for which there were previously no FDA-approved treatments for teenagers and few options for adults. LITFULO is a kinase inhibitor that blocks Janus kinase 3 (JAK3) and the tyrosine kinase family of kinases found in hepatocellular carcinoma (TEC).

Read More On The Global Alopecia Areata Market Report Here:
https://www.thebusinessresearchcompany.com/report/alopecia-areata-global-market-report

The alopecia areata market is segmented -
1) By Type: Patchy Alopecia Areata, Alopecia Totalis, Alopecia Universalis, Diffuse Alopecia Areata, Ophiasis Alopecia, Other Types

2) By Treatment: Medical Treatments, Natural Treatment, Other Treatments

3) By Diagnosis: Trichoscopy, Skin Biopsy, Other Diagnoses

4) By Route Of Administration: Oral, Topical, Parenteral, Other Routes Of Administration

5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users

• By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the alopecia areata market.

The Business Research Company's "Global Alopecia Areata Market Report 2023" provides a thorough understanding of the market across 60 geographies. The report covers market size, growth rate, segments, drivers and trends in every region and country. In addition, the report offers insights on historical and forecast growth, helping players analyze and strategize better.

Explore Buying Options For The Alopecia Areata Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12596

The Table Of Content For The Alopecia Areata Market Include:
1. Executive Summary
2. Alopecia Areata Market Characteristics
3. Alopecia Areata Market Trends And Strategies
4. Alopecia Areata Market - Macro Economic Scenario
5. Global Alopecia Areata Market Size and Growth
……..
32. Global Alopecia Areata Market Competitive Benchmarking
33. Global Alopecia Areata Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Alopecia Areata Market
35. Alopecia Areata Market Future Outlook and Potential Analysis
36. Appendix

Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

This release was published on openPR.